Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
James Fisher and Sons plc is a British provider of specialist marine engineering services and a major shipowner, founded in 1847 in Barrow-in-Furness, Cumbria, where it maintains its headquarters. The company delivers innovative solutions across three core markets: Energy, Defence, and Maritime Transport, operating within the Blue Economy to address complex challenges in harsh ocean environments. In the Energy sector, it supports oil and gas operations, nuclear services, and offshore renewables through site preparation, installation, commissioning, and maintenance. The Defence division offers submarine rescue, special operations, diving equipment, and marine engineering for global militaries, including NATO systems and advanced technologies. Maritime Transport focuses on coastal shipping, ship-to-ship transfers, and a modern tanker fleet managed by James Fisher Everard, ensuring reliable movement of critical resources. With over 175 years of heritage, around 1,900 employees, and a global presence, James Fisher and Sons plc plays a vital role in enhancing supply chains, energy transitions, and national security through technical expertise and operational safety.
£4.63
+£0.03 (+0.65%)
EOD Jul 3, 2026
Operating margin is thin at 4.56%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue declined 9.9% YoY. Margins deteriorated 2.6pp alongside, both lines moving the wrong way.
ROIC dropped from 6.65% to 2.32%, capital efficiency is deteriorating. Net debt of £144M represents 4.2x FCF, leverage limits flexibility.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
£394M
▼ -9.9% YoY
Net Income (TTM)
-£4M
▼ -109.3% YoY
Op. Margin
4.56%
▼ -2.6pp YoY
ROIC
2.32%
▼ -4.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
£34M
▲ +92.6% YoY
Op. Cash Flow (TTM)
£55M
▼ -14.0% YoY
Net Debt
£144M
Cash & Equiv.
£59M
3Y CAGR: -6.2%
3Y CAGR: +43.4%
Continue Research
James Fisher and Sons (FSJ.XLON) trades below a two-stage DCF intrinsic value of about £11.99 per share, so at £4.63 the stock looks undervalued (158.9% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, James Fisher and Sons scores 39/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about £11.99 per share for FSJ.XLON, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around £8.99. At today's £4.63, that puts the stock about 158.9% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
James Fisher and Sons scores 39 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a 4.6% operating margin and a 2.3% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. FSJ.XLON currently trades below its estimated intrinsic value and scores 39/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.